Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Roumell Asset Management Continues Selling Transcept Pharmaceuticals

Roumell Asset Management, led by Jim Roumell, continues selling shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT). In a new filing, Roumell reported disposing 7,190 shares, reducing its exposure at the company to around 2.26 million shares. The fund sold the shares in three transactions, with the price being slightly above the $3.50 mark.

James Roumell

Disclosure: none

Recommended Reading:

Dialectic Capital Cuts Stake in Immersion Corporation

TPG Advisors Cuts Exposure at Armstrong World Industries

Jeff Ubben Helps to Recover Allison Transmission’s Face Value

Loading...